Technology companies from start-ups to Fortune 50 companies trust Mark to structure, negotiate and document technology transactions, private equity financings, and mergers and acquisitions. Mark’s clients span the globe and operate throughout the technology ecosystem, including software, cybersecurity, fintech, cleantech, biotech, and medical devices.
Technology and Intellectual Property Transactions
Mark negotiates a wide range of technology and intellectual property agreements, including patent, software, and technology licenses, strategic agreements, joint ventures, and development agreements. These agreements involve private parties, universities, and research institutions. He also handles complex software development agreements, distribution agreements, manufacturing agreements, sales agreements, and other commercial agreements, often internationally.
Mark's represents leading Israeli high-tech and life sciences companies, as well as other foreign-based companies doing business in the United States.
Emerging Companies, Investments, and Mergers & Acquisitions
Mark represents clients in preferred stock investments from leading U.S. and international venture capital, corporate venture capital, and private equity funds, on both the issuer and investor sides.
He has represented clients in acquisitions by foremost global technology companies. On the buy side, he has represented leading global technology and pharmaceutical companies and private equity funds in acquisitions.
Mark is a member of Crowell & Moring's Privacy and Cybersecurity Group, as well as the firm’s Corporate Group.
Insights
Speeches & Presentations
-
“Arbitration in Times of Conflict,” Tel Aviv Arbitration Week, Tel Aviv, Israel.
(March 3, 2023).
Speakers: Nimi Aviad, Lauren Blanchard, Mark Kass, Ian Laird, Stu Newberger, Uri Niv, Aryeh Portnoy, David Ramm, and Laurence Winston.
-
"U.S. Cross-Border Transaction Environment Managing Regulatory Risks and Rules," Association of Corporate Counsel Israel Webinar
(April 22, 2020).
Presenters: Adelicia R. Cliffe, Samuel E. Feigin, and Mark Kass.
-
"Antitrust Implications in International Agreements," Association of Corporate Counsel Israel
(December 12, 2017).
Presenter: Mark Kass.
-
"New Heart: Issues in Intellectual Property Rights, FDA & Risk Mitigation," Tel Aviv Crowne Plaza
(December 11, 2017).
Panelist: Mark Kass.
-
"M&A in the Cybersecurity Space," HLS & Cyber 2016 Conference
(November 15, 2016).
Presenter: Mark Kass.
-
"Business & Legal Considerations in Establishing a Successful Digital Health Platform," Fostering Innovative Digital Health Strategies Conference
(June 23, 2016).
Presenter: Mark Kass.
-
"Cybersecurity: U.S. Trends in Risk Management," U.S. Cybersecurity and Homeland Security Conference
(November 17, 2015).
Panelist: Mark Kass.
-
"Cybersecurity Risk: The Roles of Board Directors and In-House Counsel," Association of Corporate Counsel Israel
(November 16, 2015).
Presenter: Mark Kass.
-
"Collaborative Agreements in Life Sciences," 5th Molecular Diagnostics for Cancer Drug Development Conference
(June 20, 2013).
Panelist: Mark Kass.
-
"Collaborative Agreements in Life Sciences," 5th World Companion Diagnostics Summit
(November 20, 2012).
Panelist: Mark Kass.
-
"Leveraging Philanthropic Capital to Fund Life Science Companies and University Spin-outs," Webinar
(September 20, 2012).
Co-Presenter: Mark Kass.
-
"Collaborative Agreements in Life Sciences," 4th Molecular Diagnostics for Cancer Drug Development Conference
(June 20, 2012).
Panelist: Mark Kass.
-
"M&A Prospects and Perspectives," Washington, D.C.
(March 20, 2012).
Presenter: Mark Kass.
-
"Collaborative Agreements in Life Sciences," 4th World Companion Diagnostics Summit
(November 20, 2011).
Panelist: Mark Kass.
-
"How to Best Position Your Company for an M&A or Public Offering," Washington, D.C.
(March 20, 2011).
Presenter: Mark Kass.
-
"Business Opportunities in Homeland Security and Defense," Tel Aviv, Israel
(March 20, 2010).
Presenter: Mark Kass.
-
"Fundamentals of Life Sciences Licensing," Maryland Tech Council
(May 20, 2008).
Presenter: Mark Kass.
Publications
Press Coverage
Firm News & Announcements
| January 9, 2023 |
Crowell & Moring Elects 16 New Partners, Promotes Five to Senior Counsel, and 25 to Counsel |
| July 15, 2022 |
DEAL NOTE: Crowell Advises Bishop Fox in $75 Million Series B Financing |
| December 6, 2021 |
DEAL NOTE: Crowell & Moring Advises BayWa Venture GmbH in YoFix Probiotics Investment |
| September 14, 2021 |
DEAL NOTE: Crowell & Moring Represents Honeywell in Investment in Aviation Biofuels Company Alder Fuels |
| February 10, 2021 |
DEAL NOTE: Crowell & Moring Represents Kountable in Series A-1 Financing Lead by Lateral Capital |
| October 10, 2016 |
Crowell & Moring's Pro Bono Efforts in D.C. Honored by DC Appleseed Center for Law & Justice |
| August 18, 2016 |
Deal Note: Crowell & Moring Represents REAN Cloud in Acquisition of Opex Software |
| May 19, 2016 |
Deal Note: Crowell & Moring Represents REAN Cloud in a Strategic Investment from BV Investment Partners and TriCore Solutions, LLC. |